MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,396K
EPS
-$0.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-09-30
General and administrative expense, total
5,655
Research and development expense, total
20,527
Total operating expenses
26,182
Loss from operations
-26,182
Fair value adjustment of warrants
-20,305
Interest expense
1,312
Interest income
793
Net loss applicable to common stockholders
-6,396
Basic EPS
-0.16
Diluted EPS
-0.16
Basic Average Shares
39,335,772
Diluted Average Shares
39,335,772
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss applicable
to common...
-$6,396K
Fair value
adjustment of warrants
-$20,305K
Interest income
$793K
Loss from operations
-$26,182K
Interest expense
$1,312K
Total operating
expenses
$26,182K
Research and development
expense, total
$20,527K
General and
administrative expense, total
$5,655K
Buy us a coffee
Syros Pharmaceuticals, Inc. (SYRS)
Syros Pharmaceuticals, Inc. (SYRS)